Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-25 Purchase |
2021-01-27 5:43 pm |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner |
311,111 | $22.5 | $6,999,998 | 3,425,916 (Indirect) |
View |
| 2020-09-22 Purchase |
2020-09-22 7:11 pm |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner |
1,058,824 | $17 | $18,000,008 | 3,114,805 (Indirect) |
View |
| 2020-09-22 Purchase |
2020-09-22 6:03 pm |
Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director 10% Owner |
1,058,824 | $17 | $18,000,008 | 3,114,805 (Indirect) |
View |
| 2020-09-18 Purchase |
2020-09-22 5:03 pm |
Athira Pharma Inc. | ATHA | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
750,000 | $17 | $12,750,000 | 2,668,913 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-28 Option Award |
2021-06-01 6:13 pm |
N/A 2031-05-27 |
Athira Pharma Inc. | ATHA | Yamada Tadataka Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-01 6:11 pm |
N/A 2031-05-27 |
Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-01 6:06 pm |
N/A 2031-05-27 |
Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director |
13,871 | $0 | 13,871 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:38 pm |
N/A 2031-03-03 |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
27,742 | $0 | 27,742 (Direct) |
View |
Ownership |
2021-03-08 4:29 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Kosacz Barbara Director |
0 | $0 | 0 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 5:39 pm |
N/A 2031-02-17 |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
72,000 | $0 | 72,000 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 5:38 pm |
N/A 2031-02-17 |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
73,500 | $0 | 73,500 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 5:36 pm |
N/A 2031-02-17 |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 5:33 pm |
N/A 2031-02-17 |
Athira Pharma Inc. | ATHA | KAWAS LEEN President & CEO |
231,000 | $0 | 231,000 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 5:31 pm |
N/A 2031-02-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-03 Exercise |
2021-02-04 8:18 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director |
25,220 | $1.19 | 150,615 (Direct) |
View |
| 2021-02-03 Exercise |
2021-02-04 8:18 pm |
N/A 2027-12-12 |
Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director |
29,003 | $0 | 150,615 (Direct) |
View |
| 2021-02-03 Exercise |
2021-02-04 8:18 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director |
3,783 | $1.35 | 150,615 (Direct) |
View |
Ownership |
2021-01-08 9:49 pm |
N/A 2030-12-10 |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
0 | $0 | 28,057 (Direct) |
View |
| 2020-12-22 Ownership |
2021-01-08 9:49 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
315 | $31.74 | 28,057 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-14 7:24 pm |
N/A 2030-12-10 |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
27,742 | $0 | 27,742 (Direct) |
View |
Ownership |
2020-12-14 7:19 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Romano Kelly A Director |
0 | $0 | 0 (Direct) |
View |
| 2020-09-22 Conversion |
2020-09-22 7:11 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner |
1,644,785 | $0 | 3,114,805 (Indirect) |
View |
| 2020-09-22 Conversion |
2020-09-22 6:03 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director 10% Owner |
1,644,785 | $0 | 3,114,805 (Indirect) |
View |
| 2020-09-22 Conversion |
2020-09-22 5:16 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director |
71,172 | $0 | 121,612 (Direct) |
View |
| 2020-09-22 Conversion |
2020-09-22 5:15 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
32,815 | $0 | 70,129 (Direct) |
View |
| 2020-09-18 Conversion |
2020-09-22 5:03 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
1,535,131 | $0 | 2,668,913 (Indirect) |
View |
Ownership |
2020-09-18 6:21 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director |
0 | $0 | 178,357 (Direct) |
View |
Ownership |
2020-09-17 9:05 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner |
0 | $0 | 2,083,723 (Indirect) |
View |
Ownership |
2020-09-17 8:36 pm |
N/A 2030-09-16 |
Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director |
0 | $0 | 27,742 (Direct) |
View |
Ownership |
2020-09-17 8:35 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director 10% Owner |
0 | $0 | 2,083,723 (Indirect) |
View |
Ownership |
2020-09-17 8:34 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | Yamada Tadataka Director |
0 | $0 | 109,707 (Direct) |
View |
Ownership |
2020-09-17 8:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
0 | $0 | 281,232 (Direct) |
View |
Ownership |
2020-09-17 8:31 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
0 | $0 | 129,880 (Direct) |
View |
Ownership |
2020-09-17 8:30 pm |
N/A 2029-06-25 |
Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer |
0 | $0 | 189,150 (Direct) |
View |
Ownership |
2020-09-17 8:29 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | MILESON GLENNA Chief Financial Officer |
0 | $0 | 189,780 (Direct) |
View |
Ownership |
2020-09-17 8:27 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | KAWAS LEEN President & CEO 10% Owner |
0 | $0 | 1,913,567 (Direct) |
View |
Ownership |
2020-09-17 8:08 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
0 | $0 | 1,918,913 (Indirect) |
View |